LY-293111
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY-293111, covering 2013-06-18 to 2013-06-18. Get the full timeline:
Most recent: Clinical Trial Update: LY293111 in Treating Patients With Advanced Solid Tumors [Phase 1]